Lethal multiple sclerosis relapse after natalizumab withdrawal.
Neurology
; 79(22): 2214-6, 2012 Nov 27.
Article
in En
| MEDLINE
| ID: mdl-23100404
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Multiple Sclerosis, Relapsing-Remitting
/
Antibodies, Monoclonal, Humanized
Type of study:
Diagnostic_studies
Limits:
Adult
/
Humans
/
Male
Language:
En
Journal:
Neurology
Year:
2012
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos